OGT at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
OGT brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 437. Its program centres on next-generation sequencing for hematologic malignancies, including ultra-sensitive approaches to acute myeloid leukemia measurable residual disease testing. The company supplies FISH probes, microarrays and NGS panels for genetic diagnostics and is part of Sysmex.
| Organization | AMP 2026 Attendance |
|---|---|
OGT Oxford, UK | |
FISH probes, microarrays and NGS panels for genetic diagnostics, with a focus on haematological malignancies. Part of Sysmex. | Booth Exhibiting at Booth 437 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 12:00pm–12:50pm Lessons Learned: Evaluating Ultra-High Sensitive NGS in the Future of AML MRD Testing Ultra-sensitive sequencing for measurable residual disease in acute myeloid leukaemia, tested on a retrospective treatment cohort. Workshop Wed, Nov 11 2:00pm–2:50pm See More, Sooner: Integrated NGS for Deeper Hematologic Insights RNA-based fusion panels combined with custom cancer panels to detect fusions, copy number and point mutations in blood cancers. |
Instantly find 20 buyers from OGT
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction